T racheostomy is a common procedure performed in the intensive care unit (ICU) when prolonged mechanical ventilation (MV) is anticipated, as the latter is associated with high ICU mortality and impaired post-ICU discharge healthrelated quality of life (1) . The marked increase in the implementation of this practice during the past decade (2) may partly be explained by the development of the percutaneous dilational technique, which allows easy and rapid placement of the tracheal cannula at the bedside by trained intensivists (3) . Indeed, tracheostomy has many potential advantages over translaryngeal intubation. It decreases airway resistance (even for tubes of identical inner diameter) (4) , is responsible for fewer oral-labial ulcerations, facilitates oral hygiene (5), eases bronchopulmonary toilet, and improves airway security. It might also contribute to fewer pulmonary infections (5) and improved patient comfort (6) . Moreover, our group recently demonstrated that tracheostomy led to less sedative administration, less time spent heavily sedated, and enhanced patient mobility and ability to be fed orally (7) . However, the effect of tracheostomy on ICU and in-hospital outcomes remains heatedly debated (8 -12) , and to date, only one published prospective, randomized study, which evaluated the effect of early vs. late tracheostomy, demonstrated that tracheostomized patients had lower ICU and in-hospital mortality rates and spent less time on MV (5) .
Therefore, the objectives of this study were to evaluate the effect of tracheostomy on the outcomes of patients requiring prolonged (Ͼ3 days) MV in our medical-surgical ICU. Two types of analyses were conducted: a population-based cohort study that used multivariable logistic-regression analyses and a case-control study that applied a propensity score for performing tracheostomy that adjusted for potential residual confounding.
METHODS
This study was conducted in accordance with the ethical standards of our hospital's Committee for the Protection of Human Subjects. Informed consent was not obtained because this observational study did not modify existing diagnostic or therapeutic strategies.
Study Population. We retrospectively analyzed the charts of the 1,629 consecutive patients admitted to our 18-bed referral medical-surgical ICU between January 2002 and December 2004. We included patients mechanically ventilated and not tracheostomized at ICU admission and who underwent prolonged (Ͼ3 days) MV. The following data were recorded at ICU admission: age; sex; severity of underlying medical condition according to the criteria of McCabe and Jackson (13); immuno-compromised status; admission category (classified as medical, scheduled or unscheduled surgery); and admission source, specifically, patients directly admitted from the emergency room or from the Paris area emergency medical teams (direct), those referred from wards in our hospital or another (ward), or those transferred from another ICU (ICU transfer) (14) . Primary ICU admission diagnosis was categorized as follows (14) : respiratory diseases (including asthma, respiratory failure, pulmonary embolism, pneumothorax, and hemoptysis, but excluding pulmonary and pleural infections), cardiac diseases (including acute coronary syndromes, congestive heart failure, cardiogenic shock, arrhythmias, and cardiac arrest), sepsis (including all septic conditions at ICU admission), neurologic diseases (including seizures, status epilepticus, intracranial hemorrhage, stroke, and coma, but excluding meningitis), and other diagnoses (not belonging to the former classes).
In addition, the following variables were recorded within the first 24 hrs of ICU admission: Simplified Acute Physiology Score II (range, 0 -174) (15) , presence or absence of Organ Dysfunctions and/or INfection (ODIN) score (16) , leukocyte count, blood hematocrit, serum creatinine, and presence of acute respiratory distress syndrome (ARDS) (17) . Finally, the number of organs failing according to the ODIN score was also recorded on day 3 after ICU admission.
Study Design. Two types of analyses were performed to evaluate the effect of tracheostomy on the outcome of patients with prolonged MV. The first was a population-based cohort study that used univariable and multivariable logistic-regression analyses with ICU and in-hospital deaths as dependent variables. However, because patients on MV were not randomly assigned to undergo tracheostomy or conventional orotracheal intubation, potential confounding (i.e., selection biases) was also adjusted for by constructing a nested case-control population and applying a propensity score for the matching procedure. Briefly, stepwise logistic-regression analyses were used to select baseline variables that were associated with tracheostomy. All univariable predictors of tracheostomy with p Ͻ .25 were entered into the multivariable model predicting tracheostomy. A backward stepwise elimination process was then used to remove covariates that had multivariable p values of Ͼ.25. Then, using the coefficients of the final regression equation, a propensity score for undergoing tracheostomy was calculated for each patient. Thereafter, each patient undergoing tracheostomy was matched to a single control patient who had a similar propensity score (within .05 on a scale from 0 to 1) and for whom MV duration was at least equal to the time from MV onset to tracheostomy of the paired case. When more than one control was identified for a case, the closest admission date was used to select the control patient.
Tracheostomy Procedure. The decision to perform tracheostomy in our department is based on the clinical consensus of all the ICU intensivists gathered at our daily staff meetings. Patients are tracheostomized after a few days of MV, when prolonged MV duration is anticipated because of prolonged or unsuccessful respiratory weaning, patients' inability to clear abundant bronchopulmonary secretions, persistent ARDS, continued low level of consciousness, or ICU-acquired paresis. We have been using the percutaneous dilational technique for tracheostomy in our ICU for Ͼ8 yrs. The entire procedure, including needle and Seldinger wire insertion and Blue Rhino dilation (Ciaglia Blue Rhino percutaneous tracheostomy kit, William Cook Europe, Bjaeverskov, Denmark), is performed under direct bronchoscopic guidance, while patients are placed on supplemental oxygen (FIO 2 ϭ 1). At the end of the procedure, accurate placement of the tracheal cannula is verified with the bronchoscope, and an extensive tracheobronchial toilet is performed. Finally, a chest radiograph is obtained to detect any potential complications of the procedure, such as pneumothorax or atelectasis.
MV Weaning Protocol. As recommended by Ely et al. (18) , patients on MV in our ICU are screened daily for the presence of criteria of successful weaning: patient calm and awakened, with no sedative drugs except intermittent boluses of sedatives; no vasoactive support except for dobutamine of Յ15 g·kg Ϫ1 ·min Ϫ1 ; PaO 2 /FIO 2 of Ͼ200; positive end-expiratory pressure of Յ5 cm H 2 O; adequate cough during suctioning; and respiratory frequency/tidal volume ratio of Ͻ105 for patients breathing spontaneously with a continuous positive airway pressure of 5 cm H 2 O. Patients who pass this screening test undergo a 1-hr trial of spontaneous breathing (18) , which is rapidly stopped if any of the following conditions are identified: respiratory rate of Ͼ35 breaths/min, arterial oxygen saturation of Ͻ90%, heart rate of Ͼ140 beats/min or Ͼ20% increase or decrease of heart rate, systolic blood pressure of Ͼ180 mm Hg or Ͻ90 mm Hg, anxiety, or sweating. Patients who tolerate this 1-hr trial are extubated, unless they are unable to clear secretions or protect their airway against aspiration.
For tracheostomized patients on MV, daily doses of intravenous sedatives are rapidly decreased (7) and trials of spontaneous breathing are undertaken when patients satisfy the same criteria as above. When 48 hrs of spontaneous breathing have been completed and if the patient is able to clear bronchopulmonary secretions, the tracheal cannula is removed. It should be noted that, because we do not have local access to a long-term ventilation unit caring for tracheostomized patients, these patients remain in our care until they become completely ventilator and cannula independent.
Outcome Measures and Resource Utilization. Outcome measures included: ICU and in-hospital mortality rates, duration of MV, and length of ICU stay. The Omega score for workload quantification was calculated at ICU discharge (19) . This score is divided into three subscores: Omega 1 corresponds to general ICU procedures (28 items recorded only once during a stay), Omega 2 concerns specific ICU procedures (11 items recorded every time one of these interventions is performed), and Omega 3 (eight items recorded every day and MV duration and length of ICU stay). The total Omega score is obtained by adding all Omega points on the last ICU day. Finally, red blood cell transfusion and renal replacement therapy were also noted.
Statistical Analyses. Continuous variables were compared with Student's t-test or the Mann-Whitney U test, as appropriate. Categorical variables were compared with chi-square tests. To examine the univariate effects of patients' clinical characteristics on the outcome of interest, a logistic-regression model was used to test each characteristic. Factors with p Յ .10 in our univariable analysis were entered into the models. Thereafter, we carried out multiple logistic regressions using backward stepwise variable elimination (with variable exit threshold set at p Ͼ .05) (20) . All potential explanatory variables included in the multivariable analyses were subjected to a correlation matrix for analysis of collinearity. Variables with associations among each other were not included in the multivariable models. Interactions were explored between the substantive variables that remained in the multivariable models. Further adjustment for confounding was performed by forcing the propensity score for tracheostomy into the final multivariable logistic regression models.
Concerning the case-control study, continuous variables were compared using a matched Student's t-test, and the McNemar test was used to compare dichotomous variables. Conditional logistic-regression analysis was then used to calculate the odds ratios for mortality.
Cumulative-event curves were estimated with the Kaplan-Meier method and the groups compared using the log-rank test. For patients who were discharged alive from the hospital and free from assisted breathing, we assumed that they were still alive 140 days after ICU admission (the longest ICU stay for a patient who ultimately died in our hospital).
Statistical significance was defined as p Ͻ .05. Analyses were performed using StatView 5.0 (SAS Institute, Cary, NC) and SPSS 11.5 (SPSS, Chicago, IL) software.
RESULTS

Study Population and Main Outcomes.
Among the 506 patients on MV for Ͼ3 days, 166 were tracheostomized after a median of 12 days of MV (range, 4 -30 days; interquartile range, 7-15 days). ICU admission and day-3 clinical characteristics of tracheostomized and nontracheos-tomized patients are reported in Table 1 . The percentages of patients with ARDS at ICU admission and who had undergone heart surgery were higher for the tracheostomy group. Main outcomes differed significantly between the two patient groups ( In addition, after forcing the propensity score into the logistic regression models along with other covariates, results were comparable with those described above, especially regarding the effect of tracheostomy on mortality.
Matched Case-Control Study. Factors associated with tracheostomy for the 506 patients on MV for Ͼ3 days were immunocompromised status (OR, 1.44), ARDS at ICU admission (OR, 1.98), patients being referred from another ICU (OR, 1.36), heart surgery patients (OR, 1.56), respiratory diseases as primary ICU admission diagnoses (OR, 1.46), and the admission classes medical (OR, 2.27) and elective surgery (OR, 2.19). We were able to match 120 of the 166 tracheostomized patients who had undergone tracheostomy to 120 individual controls using the propensity score-based algorithm. No significant differences were detected between these two groups concerning ICU admission and day-3 clinical characteristics (Table 4) . Tracheostomized patients had significantly lower ICU (33% vs. 47%, p ϭ .02) and hospital (36% vs. 50%, p ϭ .02) mortality rates, longer durations of MV and ICU stays (Table 5 ). It should be noted that ICU and in-hospital mortality rates did not statistically differ between patients included or not included in the case-control study. Although the total workload as measured by the Omega score was higher for tracheostomized patients, per-day Omega scores were lower Kaplan-Meier estimates of the cumulative probability of survival as a function of the number of days after ICU admission differed significantly between the two groups, with fewer fatal outcomes for tracheostomized patients (Figure 1 ).
DISCUSSION
The main findings of our study are that tracheostomy performed in our ICU on long-term (Ͼ3 days) MV patients was associated with lower ICU and hospital mortality rates, even after carefully controlling for ICU admission and day-3 clinical and physiologic differences between groups.
To date, most of the potential advantages attributed to tracheostomy over prolonged translaryngeal intubation have been based on consensus opinions (21) (22) (23) . However, the real effect of tracheostomy on the outcomes of long-term MV patients has been the subject of intense debates during the past decade. Observational cohort studies have yielded mixed results. Kollef et al. (12) studied 521 patients on MV for Ͼ12 hrs and showed that the 51 tracheostomized patients had lower ICU and hospital mortality rates, despite having similar disease severity at ICU admission. Analyses of the Project Impact database gave similar results, with fewer ICU and hospital deaths for tracheostomized patients, even though no adjustments were made for betweengroups differences in patients' characteristics (10) . According to a multiple-center international observational cohort of Ͼ5,000 patients on MV for Ͼ12 hrs, among whom 546 were tracheostomized, the procedure was associated with fewer deaths in the ICU but comparable inhospital mortality (9) . A major strength of our study, which demonstrated that both ICU and in-hospital mortality rates were lower for tracheostomized patients, was to adjust for the most significant variables associated with ICU or inhospital mortality and to derive a nested case-control study constructed using a propensity score for tracheostomy, which led to two fully comparable groups of patients on long-term MV.
Studies comparing early vs. late tracheostomies have also given mixed results (5, 24 -27) . In a recent metaanalysis of randomized trials comparing early vs. late tracheostomy for patients at risk for prolonged MV (11), the procedure was proven to shorten MV durations and ICU stays, whereas the lower mortality rate did not reach statistical significance (OR, 0.79; 95% CI, 0.45-1.39). A recently completed French randomized cohort study of early tracheostomy also did not show a survival benefit for tracheostomized patients (28) , but that study was sorely underpowered, as it was stopped because of too few inclusions after enrollment of only 25% of the planned number of patients. Conversely, the latest published trial on the subject demonstrated significantly fewer deaths for patients tracheostomized within 48 hrs after MV initiation (5). Reduced sedative administration (5, 7) and a lower frequency of ventilator-associated pneumonia (5, 27) might be among the factors potentially contributing to better outcomes for patients tracheostomized early after initiation of MV in these studies.
However, the nature of the association between tracheostomy and better outcomes reported in nonrandomized cohort studies of tracheostomized vs. nontracheostomized patients (2, 9, 10, 12), including this one, remains unclear. To date, there is no proven benefit of the procedure itself or related care, and it might be that, after 10 -15 days of MV, ICU physicians adequately select candidates for tracheostomy, based on the highest probability of MV weaning failure associated with a reasonable probability of ICU survival. Indeed, the major limitation when evaluating survival using retrospective cohort studies, even when sophisticated adjustment methods such as multivariable analyses or propensity score-based nested case-control studies are applied, is to miss important confounding factors among the variables chosen for adjustment. In accordance with our results, several investigators (9, 10, 12) reported that factors significantly associated with performing tracheostomy could be determined early after MV initiation. Those factors include significant co-morbidities, such as immunocompromised status or specific ICU admission-diagnosis categories, for example, neurologic or respiratory diseases as the reason for ICU admission, trauma or surgical patients, or hospitalization in an academic center. However, because tracheostomy was performed after a median of 12 days of MV, we might have missed, in the present study, other important factors associated with the decision to perform a tracheostomy that might also alter ICU and hospital outcomes. These factors might include prolonged MV duration because of weaning failure, need for reintubation, nosocomial pneumonia, or aspiration (9, 12) . Adjustment to serial severity of illness scores (such as daily Sequential Organ Failure Assessment or ODIN) might also have reduced the effect of tracheostomy on outcomes. Unfortunately, these data were not collected in the charts of our patients.
We recognize several other limitations of the present study. First, it was performed in a single ICU with a high rate of patients with major complications of cardiac surgery. Hence, our results may not be applicable to patients receiving MV in other centers with different case-mixes and different MV weaning strategies. Second, we did not record decisions to withhold or withdraw life-sustaining treatments either in our unit or after discharge from it. Such decisions might have affected the outcomes of our control group. Finally, we have not evaluated long-term clinical and functional outcomes after hospital discharge for our tracheostomized and nontracheostomized long-term MV patients. These data might be the focus of future studies.
In conclusion, the results of this study demonstrate that physicians treating these long-term MV patients were able to adequately select for tracheostomy the population of patients who, despite having similar physiologic and demographic variables, had the highest probabilities of both ICU and hospital survival. Whether tracheostomy really affects the outcomes of these long-term MV patients will remain speculative until the large-scale and adequately powered randomized, controlled trials (29 -31) , currently in progress, are completed and their data published. 
